Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Fasting 9 Prostatic Neoplasms 3 Breast Neoplasms 3 Intermittent Fasting 2 Polycystic Ovary Syndrome 1 Ovarian Neoplasms 1 Neoplasms 1 Lymphoma 1 Infertility 1 Glioma 1 Fibrosis 1 Fasting in Malignant Solid Tumors 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Childhood Cancer Survivors 1

Interventions

Temozolomide 109 Magnetic Resonance Spectroscopy 52 Bevacizumab 52 Radiotherapy 44 Irinotecan 27 Blood Specimen Collection 19 Surgical Procedures, Operative 16 Radiation 15 Aminolevulinic Acid 15 Carboplatin 13 fluorodopa F 18 12 Nivolumab 12 Radiotherapy, Intensity-Modulated 11 Carmustine 11 Radiosurgery 10 Magnetic Resonance Imaging 10 pembrolizumab 9 Topotecan 9 Specimen Handling 9 Everolimus 9 Erlotinib Hydrochloride 9 Biopsy 9 poly ICLC 8 Surveys and Questionnaires 8 Standard of Care 8 Etoposide 8 Drug Therapy 8 Lomustine 7 Filgrastim 7 Cyclophosphamide 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Glioma × Angptl4 protein, mouse × Clear all

NCT04461938 2024-10-17

ERGO3

Goethe University

Phase NA Active not recruiting

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡